文献速递关节外科创伤骨科骨质疏松与代谢性骨病

中国髋关节置换术后院内死亡率:大型全国数据库分析

In-hospital mortality after hip arthroplasty in China: analysis of a large national database.
PubMed 文献 · Bone Joint J · 2019-01-01

高龄、男性、离异或丧偶患者死亡率更高;骨折后置换的死亡风险比慢性病高(RR 2.0,95%CI 1.5-2.6);CCI 1-2和CCI≥3的RR分别为3.3(95%CI 2.7-3.9)和8.2(95%CI 6.5-10.4)。

要点

  • 中国髋关节置换术后院内死亡率从2013年2.9%降至2016年2.6%(趋势p=0.02)。
  • 骨折后置换死亡风险约为慢性病的2倍(RR 2.0,95%CI 1.5-2.6)。
  • CCI≥3患者死亡风险约为CCI 0的8.2倍(95%CI 6.5-10.4)。

核心结论

  • 中国髋关节置换术后院内死亡率较低且研究期间下降,但死亡率随社会人口学因素存在差异。

主要发现

  • 研究期间30天内发生626例住院死亡。
  • 死亡率从2013年2.9%降至2016年2.6%(趋势p=0.02)。
  • 高龄、男性、离异或丧偶患者死亡率更高(均p<0.05)。
  • 骨折后置换死亡风险比慢性病高(RR 2.0,95%CI 1.5-2.6)。
  • 与CCI 0相比,CCI 1-2的RR为3.3(95%CI 2.7-3.9),CCI≥3的RR为8.2(95%CI 6.5-10.4)。

关键数值与推荐

  • 死亡率地区分布:East 1.8%,Beijing 2.1%,North 2.9%,South-West 3.6%,South-Central 3.8%,North-East 4.1%,North-West 5.2%。

临床怎么用

  • 医疗卫生资源应更多分配给欠发达地区以进一步降低死亡率(原文结论)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: There is an increasing demand for hip arthroplasty in China. We aimed to describe trends in in-hospital mortality after this procedure in China and to examine the potential risk factors. PATIENTS AND METHODS: We included 210 450 patients undergoing primary hip arthroplasty registered in the Hospital Quality Monitoring System in China between 2013 and 2016. In-hospital mortality after hip arthroplasty and its relation to potential risk factors were assessed using multivariable Poisson regression. RESULTS: During the study period, 626 inpatient deaths occurred within 30 days after hip arthroplasty. Mortality decreased from 2.9% in 2013 to 2.6% in 2016 (p for trend = 0.02). Compared with their counterparts, old age, male sex, and divorced or widowed patients had a higher rate of mortality (all p < 0.05). Risk ratio (RR) for mortality after arthroplasty for fracture was two-fold higher (RR 2.0, 95% confidence interval (CI) 1.5 to 2.6) than that for chronic disease. RRs for mortality were 3.3 (95% CI 2.7 to 3.9) and 8.2 (95% CI 6.5 to 10.4) for patients with Charlson Comorbidity Index (CCI) of 1 to 2 and CCI ≥ 3, respectively, compared with patients with CCI of 0. The rate of mortality varied according to geographical region, the lowest being in the East region (1.8%), followed by Beijing (2.1%), the North (2.9%), South-West (3.6%), South-Central (3.8%), North-East (4.1%), and North-West (5.2%) regions. CONCLUSION: While in-hospital mortality after hip arthroplasty in China appears low and declined during the study period, discrepancies in mortality after this procedure exist according to sociodemographic factors. Healthcare resources should be allocated more to underdeveloped regions to further reduce mortality. Cite this article: Bone Joint J 2019;101-B:1209-1217.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Zeng C, Lane NE, Englund M, et al. In-hospital mortality after hip arthroplasty in China: analysis of a large national database. Bone Joint J. 2019. PMID: 31564156. doi:10.1302/0301-620X.101B10.BJJ-2018-1608.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。